Argenx
ARGX
#629
Rank
ยฃ24.67 B
Marketcap
ยฃ407.07
Share price
0.98%
Change (1 day)
-3.62%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ3.24 B

According to Argenx 's latest financial reports the company has ยฃ3.24 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$ยฃ2.32 B24.2%
2021-12-31$ยฃ1.87 B24.92%
2020-12-31$ยฃ1.49 B50.09%
2019-12-31$ยฃ0.99 B80.63%
2018-12-31$ยฃ0.55 B50.51%
2017-12-31$ยฃ0.36 B546.61%
2016-12-31$ยฃ56.81 M89.43%
2015-12-31$ยฃ29.99 M-37.02%
2014-12-31$ยฃ47.62 M89.94%
2013-12-31$ยฃ25.07 M84.21%
2012-12-31$ยฃ13.61 M-41.61%
2011-12-31$ยฃ23.3 M164.15%
2010-12-31$ยฃ8.82 M